Financials Genmab A/S

Equities

GMAB

DK0010272202

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 21/01/2025 GMT			5-day change	1st Jan Change
1,535.50 ^DKK	+1.69%		-2.51%	+2.88%

01-14	Genmab A/S Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 03:00 PM
01-02	A poor 2024 increases the odds of a brighter 2025

Projected Income Statement: Genmab A/S

income-statement-evolution-chart GENMAB-A-S

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	5,366	10,111	8,482	14,595	16,474	21,234	24,886	29,093
Change	-	88.43%	-16.11%	72.07%	12.87%	28.89%	17.2%	16.91%
EBITDA ¹	2,777	6,572	3,266	6,719	5,616	6,860	8,362	10,210
Change	-	136.66%	-50.3%	105.73%	-16.42%	22.14%	21.9%	22.09%
EBIT ¹	2,638	6,313	3,018	6,357	5,321	6,432	7,518	9,696
Change	-	139.31%	-52.19%	110.64%	-16.3%	20.87%	16.89%	28.96%
Interest Paid ¹	-7	-1,558	-702	-680	-942	-1,094	-339.3	-275
Earnings before Tax (EBT) ¹	2,859	5,904	3,983	7,035	5,637	7,465	8,094	10,445
Change	-	106.51%	-32.54%	76.63%	-19.87%	32.43%	8.43%	29.05%
Net income ¹	2,166	4,758	3,008	5,522	4,352	5,556	6,275	8,030
Change	-	119.67%	-36.78%	83.58%	-21.19%	27.67%	12.93%	27.98%
Announcement Date	19/02/20	23/02/21	16/02/22	22/02/23	14/02/24	-	-	-

¹DKK in Million

Estimates

Fiscal Period: December	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4
Net sales ¹	2,961	892	5,451	1,724	2,044	1,581	1,972	2,310	2,619	2,119	3,162	4,087	5,227	2,854	4,198	4,744	4,678	4,143	5,402	5,540	6,321	4,905	6,173	6,474	6,624
Change	-	-69.88%	511.1%	-68.37%	18.56%	-22.65%	24.73%	17.14%	13.38%	-19.09%	49.22%	29.25%	27.89%	-45.4%	47.09%	13.01%	-1.39%	-11.44%	30.39%	2.55%	14.1%	-22.41%	25.86%	4.86%	2.32%
EBITDA ¹	2,294	78	4,505	868	1,121	543	802	905	1,016	529	1,263	1,953	2,974	458	1,520	1,739	1,899	823	1,804	2,129	1,969	815.6	2,052	2,518	2,655
Change	-	-96.6%	5,675.64%	-80.73%	29.15%	-51.56%	47.7%	12.84%	12.27%	-47.93%	138.75%	54.63%	52.28%	-84.6%	231.88%	14.41%	9.2%	-56.66%	119.2%	18.02%	-7.53%	-58.57%	151.6%	22.73%	5.43%
EBIT ¹	2,176	71	4,497	858	887	532	787	890	809	514	1,247	1,931	2,665	437	1,497	1,717	1,670	801	1,640	2,102	1,956	589.2	1,679	2,030	2,069
Change	-	-96.74%	6,233.8%	-80.92%	3.38%	-40.02%	47.93%	13.09%	-9.1%	-36.46%	142.61%	54.85%	38.01%	-83.6%	242.56%	14.7%	-2.74%	-52.04%	104.74%	28.17%	-6.93%	-69.88%	184.9%	20.93%	1.94%
Charge d'intérêts ¹	-1.29	-2	-3	-720	-869	-76	-3	-230	-299	-339	-200	-212	71	-435	-17	-41	-449	-13	-399	-698	-100	-10	-10	-10	-10
Earnings before Tax (EBT) ¹	1,955	354	4,328	671	551	1,424	422	1,171	966	612	2,489	3,272	662	286	1,723	2,702	926	1,716	2,127	1,719	1,975	495.9	1,657	1,973	2,158
Change	-	-81.89%	1,122.6%	-84.5%	-17.88%	158.44%	-70.37%	177.49%	-17.51%	-36.65%	306.7%	31.46%	-79.77%	-56.8%	502.45%	56.82%	-65.73%	85.31%	23.95%	-19.18%	14.9%	-74.89%	234.03%	19.08%	9.39%
Net income ¹	1,472	269	3,378	530	581	1,096	306	890	716	465	1,891	2,582	584	226	1,357	2,129	640	1,325	1,408	1,266	1,590	386.1	1,298	1,544	1,691
Change	-	-81.72%	1,155.76%	-84.31%	9.62%	88.64%	-72.08%	190.85%	-19.55%	-35.06%	306.67%	36.54%	-77.38%	-61.3%	500.44%	56.89%	-69.94%	107.03%	6.26%	-10.09%	25.58%	-75.72%	236.15%	18.99%	9.48%
Announcement Date	19/02/20	06/05/20	12/08/20	04/11/20	23/02/21	05/05/21	11/08/21	10/11/21	16/02/22	11/05/22	10/08/22	09/11/22	22/02/23	10/05/23	03/08/23	07/11/23	14/02/24	02/05/24	08/08/24	06/11/24	-	-	-	-	-

¹DKK in Million

Estimates

Fiscal Period: December	2020 S1	2021 S1	2022 S1	2023 S1	2024 S1
Net sales ¹	6,343	3,553	5,281	7,052	9,545
Change	-	-43.99%	48.63%	33.54%	35.35%
EBITDA ¹	4,583	1,345	1,792	1,978	2,627
Change	-	-70.65%	33.23%	10.38%	32.81%
EBIT ¹	4,568	1,319	1,761	1,934	2,441
Change	-	-71.13%	33.51%	9.82%	26.22%
Charge d'intérêts	-	-	-	-452	-
Earnings before Tax (EBT) ¹	4,682	1,846	3,101	2,009	3,843
Change	-	-60.57%	67.98%	-35.21%	91.29%
Net income ¹	3,647	1,402	2,356	1,583	2,733
Change	-	-61.56%	68.05%	-32.81%	72.65%
Announcement Date	12/08/20	11/08/21	10/08/22	03/08/23	08/08/24

¹DKK in Million

Estimates

Forecast Balance Sheet: Genmab A/S

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	-10,790	-16,079	-19,338	-22,324	-28,135	-17,049	-22,301	-28,196
Change	-	-249.02%	-220.27%	-215.44%	-226.03%	-160.6%	-230.81%	-226.43%
Announcement Date	19/02/20	23/02/21	16/02/22	22/02/23	14/02/24	-	-	-

¹DKK in Million

Estimates

Cash Flow Forecast: Genmab A/S

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
CAPEX ¹	79	307	252	317	366	413.4	485.1	550.6
Change	-	288.61%	-17.92%	25.79%	15.46%	12.95%	17.35%	13.5%
Free Cash Flow (FCF) ¹	1,247	6,126	1,976	3,595	7,014	4,774	5,769	7,755
Change	-	391.26%	-67.74%	81.93%	95.1%	-31.93%	20.84%	34.42%
Announcement Date	19/02/20	23/02/21	16/02/22	22/02/23	14/02/24	-	-	-

¹DKK in Million

Estimates

Forecast Financial Ratios: Genmab A/S

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Profitability
EBITDA Margin (%)	51.75%	65%	38.51%	46.04%	34.09%	32.31%	33.6%	35.09%
EBIT Margin (%)	49.16%	62.44%	35.58%	43.56%	32.3%	30.29%	30.21%	33.33%
EBT Margin (%)	53.28%	58.39%	46.96%	48.2%	34.22%	35.16%	32.53%	35.9%
Net margin (%)	40.37%	47.06%	35.46%	37.83%	26.42%	26.17%	25.21%	27.6%
FCF margin (%)	23.24%	60.59%	23.3%	24.63%	42.58%	22.48%	23.18%	26.65%
FCF / Net Income (%)	57.57%	128.75%	65.69%	65.1%	161.17%	85.93%	91.94%	96.57%
Profitability
ROA	18.35%	26.22%	13.14%	20.11%	13.31%	15.63%	15.65%	15.31%
ROE	19.64%	28.69%	14.56%	22.25%	14.78%	16.43%	16.17%	16.78%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	1.47%	3.04%	2.97%	2.17%	2.22%	1.95%	1.95%	1.89%
CAPEX / EBITDA (%)	2.84%	4.67%	7.72%	4.72%	6.52%	6.03%	5.8%	5.39%
CAPEX / FCF (%)	6.34%	5.01%	12.75%	8.82%	5.22%	8.66%	8.41%	7.1%
Items per share
Cash flow per share ¹	21.46	97.64	33.73	59.26	111.7	104.7	131.6	166.3
Change	-	355.04%	-65.45%	75.68%	88.46%	-6.25%	25.69%	26.35%
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	216.1	289.7	336.3	415.8	478.9	527.1	635.1	768.7
Change	-	34.05%	16.08%	23.63%	15.19%	10.05%	20.5%	21.03%
EPS ¹	34.03	72.21	45.54	83.65	66.02	83.93	92.19	120
Change	-	112.2%	-36.93%	83.68%	-21.08%	27.12%	9.84%	30.14%
Nbr of stocks (in thousands)	65,075	65,410	65,423	65,362	65,322	63,524	63,524	63,524
Announcement Date	19/02/20	23/02/21	16/02/22	22/02/23	14/02/24	-	-	-